Imagen de Portada

Accelerating Drug Discovery through Knowledge Sharing

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autor principal:	Rory C. McAtee
Formato:	Artículo Open Access
Publicado:	Wiley 2026
Materias:	ChemMedChem
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Inducing Targeted Protein Degradation: From Chemical Biology to Drug Discovery and Clinical Applications. Edited by Philipp Cromm
por: Kirsten McAulay
Publicado: (2024)

Current Approaches and Strategies Applied in First‐in‐class Drug Discovery
por: Idrees Mohammed, et al.
Publicado: (2024)

Direct‐to‐Biology: Streamlining the Path From Chemistry to Biology in Drug Discovery
por: Ariane F. Hübner, et al.
Publicado: (2026)

Drug Discovery Summit: 14 th Swiss Course on Medicinal Chemistry
por: Céline Schuppisser, et al.
Publicado: (2024)

Fluorescence‐Based HTS Assays for Ion Channel Modulation in Drug Discovery Pipelines
por: Jan Voldřich, et al.
Publicado: (2024)

How to Find a Fragment: Methods for Screening and Validation in Fragment‐Based Drug Discovery
por: Tim Kirkman, et al.
Publicado: (2024)

Enhancing Drug Repurposing with Consensus Docking: Discovery of Novel Discoidin Domain Receptor 1 Inhibitors
por: Jochem Nelen, et al.
Publicado: (2026)

Structure–Property Associations: Breaking Paradigms for Linking Chemical Structures and Biological Properties in Drug Discovery
por: Edgar López‐López, et al.
Publicado: (2025)

Exploiting Pharmacokinetic/Pharmacodynamic Methods for Optimizing and Accelerating Drug Development of Innovative Anti‐Infectives
por: Katharina Rox
Publicado: (2026)

Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation
por: Jinmin Miao, et al.
Publicado: (2024)

Enhancing Targeted Drug Delivery through Cell‐Specific Endosomal Escape
por: Pengwen Chen, et al.
Publicado: (2024)

Exploring Synthesis Strategies and Interactions between MOFs and Drugs for Controlled Drug Loading and Release, Characterizing Interactions through Advanced Techniques
por: Lidia E. Chiñas‐Rojas, et al.
Publicado: (2024)

Targeting Plasmodium falciparum Single‐Stranded DNA‐Binding Protein: Discovery of New Scaffold Compounds Effective against Drug‐Sensitive and Artemisinin‐Resistant Strains
por: Biswajit Naik, et al.
Publicado: (2025)

Cover Feature: Direct Inhibition of the YAP : TEAD Interaction: An Unprecedented Drug Discovery Challenge (ChemMedChem 19/2024)
por: Patrick Chène
Publicado: (2024)

Targeting N‐Methyl‐lysine Histone Demethylase KDM4 in Cancer: Natural Products Inhibitors as a Driving Force for Epigenetic Drug Discovery
por: Ilaria Cursaro, et al.
Publicado: (2024)

Small Molecule‐Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs
por: Jingjing Zhang, et al.
Publicado: (2024)

Conjugating Daunorubicin and Doxorubicin to GTP by Formaldehyde to Overcome Drug Resistance
por: Linjia Su, et al.
Publicado: (2024)

Discovery of Potent Isoindolinone Inhibitors that Target an Active Conformation of PARP1 Using DNA‐Encoded Libraries
por: Kelly A. McCarthy, et al.
Publicado: (2024)

Biosynthesis of Natural and Unnatural Perylenequinones for Drug Development
por: Zengping Su, et al.
Publicado: (2024)

Exploring the Utility of Cell‐Penetrating Peptides as Vehicles for the Delivery of Distinct Antimalarial Drug Cargoes
por: Caitlin L. Gare, et al.
Publicado: (2024)

Discovery of Palindrome Dual PPARγ‐GPR40 Agonists for Treating Type 2 Diabetes
por: Ana Rodríguez‐Luévano, et al.
Publicado: (2024)

Recent Progress on Topical Drug Therapy for Corneal Neovascularization
por: Xin‐Can Huang, et al.
Publicado: (2025)

Discovery of Novel Fluorescent Azaindoles with Cytotoxic Action in A2780 Ovarian Carcinoma Cells
por: José C. Cunha, et al.
Publicado: (2024)

Challenges for the Discovery of Non‐Covalent WRN Helicase Inhibitors
por: Alisa Heuser, et al.
Publicado: (2024)

Linker Design for the Antibody Drug Conjugates: A Comprehensive Review
por: Yaxin Lei, et al.
Publicado: (2025)

Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
por: Sadık Hüseyin Cemali, et al.
Publicado: (2025)

Discovery of New CDDO‐Imidazole Derivatives as Potential Antitumor Agents
por: Yanqing Li, et al.
Publicado: (2026)

Discovery of Novel Aminopyrimidines as Selective EP2 Receptor Antagonists
por: Isabelle Lyothier, et al.
Publicado: (2025)

From Deep Learning to the Discovery of Promising VEGFR‐2 Inhibitors
por: Mehmet Ali Yucel, et al.
Publicado: (2024)

The Multifaceted Legacy of Thalidomide: Chemistry and Biology Driving Modern Drug Design
por: Konstantina Nikovia, et al.
Publicado: (2026)

Hybrid Molecules as Efficient Drugs against Multidrug‐Resistant Malaria Parasites
por: Anne Robert, et al.
Publicado: (2025)

In Silico‐Enabled Discovery and Development of Potent and Selective CDK11 Inhibitors
por: Frankie S. Mak, et al.
Publicado: (2026)

Nonsteroidal Anti‐Inflammatory Drugs as Modulators of Cation Channels: Fenamates Repurposing in Channelopathies
por: Paola Laghetti, et al.
Publicado: (2025)

Design, Synthesis, and Biological Evaluation of Evodiamine Derivatives as Antibody–Drug Conjugate Payloads
por: Ruifeng Liu, et al.
Publicado: (2025)

A New Paradigm for Drug Deuteration Based on Computed Binding Isotope Effects
por: Agata Paneth, et al.
Publicado: (2025)

Imidazole‐Based Liposomes: Emerging pH‐Sensitive Drug Delivery Tools
por: Faeze Shojaeinia, et al.
Publicado: (2025)

Corrin Ring Modification in Peptide Drug Development – a Brief History of “Corrination”
por: Nancy Cham, et al.
Publicado: (2025)

Discovery of Truncated Cyclic Peptides Targeting an Induced‐Fit Pocket on PCSK9
por: Philipp Grosche, et al.
Publicado: (2024)

Ligand Screening and Discovery Using Cocktail Soaking and Automated Microcrystal Electron Diffraction
por: Jieye Lin, et al.
Publicado: (2025)

Azologs of the Fatty Acid Mimetic Drug Cinalukast Enable Light‐Induced PPARα Activation
por: Minh Sai, et al.
Publicado: (2024)